Hu Huang Selected Research

Leukostasis

1/2015	Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition.
1/2015	Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy.
3/2011	TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
2/2011	Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.
11/2010	Parstatin suppresses ocular neovascularization and inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hu Huang Research Topics

Disease

12	Obesity 01/2021 - 03/2012
11	Neoplasms (Cancer) 06/2021 - 06/2009
11	Body Weight (Weight, Body) 01/2021 - 10/2012
11	Insulin Resistance 01/2020 - 06/2006
10	Inflammation (Inflammations) 01/2021 - 11/2010
9	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2020 - 02/2011
8	Macular Degeneration (Age-Related Maculopathy) 07/2021 - 11/2005
6	Choroidal Neovascularization 01/2021 - 11/2010
5	Leukostasis 01/2015 - 11/2010
4	Lung Neoplasms (Lung Cancer) 06/2021 - 06/2009
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 06/2009
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2018
3	Pathologic Neovascularization 01/2020 - 01/2011
3	Type 2 Diabetes Mellitus (MODY) 08/2016 - 03/2012
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2020
2	Carcinogenesis 01/2021 - 08/2020
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 10/2020 - 09/2011
2	Retinal Degeneration 08/2020 - 02/2020
2	Ischemia 01/2019 - 09/2011
2	Hypoxia (Hypoxemia) 01/2015 - 09/2011
2	Anorexia 07/2014 - 01/2013
2	Hyperglycemia 04/2014 - 03/2014
2	Retinal Neovascularization 02/2011 - 11/2010
1	Liver Neoplasms (Liver Cancer) 06/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2021
1	Ovarian Neoplasms (Ovarian Cancer) 06/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	AIDS-Related Complex (ARC) 01/2021
1	Macular Edema 12/2020
1	Retinal Vein Occlusion 10/2020
1	Inflammatory Breast Neoplasms 08/2020
1	Glucosephosphate Dehydrogenase Deficiency 02/2020
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2020
1	Brain Neoplasms (Brain Tumor) 12/2019
1	Pathologic Processes 01/2019
1	Neuroinflammatory Diseases 01/2019

Drug/Important Bio-Agent (IBA)

13	Retinaldehyde (Retinal)IBA 01/2021 - 11/2010
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2009
9	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 08/2011
7	Long Noncoding RNAIBA 06/2021 - 04/2017
6	Insulin (Novolin)FDA Link 01/2020 - 03/2012
5	Biomarkers (Surrogate Marker)IBA 08/2020 - 09/2017
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 11/2010
5	LeptinIBA 01/2016 - 10/2012
4	ClusterinIBA 01/2020 - 01/2013
4	rho-Associated KinasesIBA 01/2020 - 10/2012
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 01/2015
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2021 - 10/2012
3	Biological ProductsIBA 12/2020 - 01/2020
3	AntioxidantsIBA 01/2020 - 03/2014
3	Blood Glucose (Blood Sugar)IBA 04/2019 - 03/2014
3	Chemokine ReceptorsIBA 01/2019 - 01/2017
3	Phosphotransferases (Kinase)IBA 01/2018 - 01/2011
3	Oxygen (Dioxygen)IBA 09/2011 - 11/2010
2	CXC ChemokinesIBA 07/2021 - 08/2020
2	Pharmaceutical PreparationsIBA 08/2020 - 01/2017
2	RNA (Ribonucleic Acid)IBA 08/2020 - 02/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	Agouti-Related ProteinIBA 01/2018 - 10/2012
2	Messenger RNA (mRNA)IBA 01/2018 - 06/2006
2	Leptin ReceptorsIBA 03/2014 - 10/2012
2	Fluorescein-5-isothiocyanate (FITC)IBA 03/2011 - 11/2010
2	Concanavalin AIBA 02/2011 - 11/2010
2	AdiponectinIBA 12/2007 - 06/2006
1	Metalloproteases (Metalloproteinases)IBA 06/2021
1	ThrombospondinsIBA 06/2021
1	Antisense RNA (Anti-Sense RNA)IBA 06/2021
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2021
1	EnzymesIBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2020
1	Glutathione (Reduced Glutathione)IBA 02/2020
1	Adenosine (Adenocard)FDA LinkGeneric 02/2020
1	NADP (NADPH)IBA 02/2020
1	Nicotine FDA Link 02/2020
1	Phosphates (Orthophosphate)IBA 02/2020
1	Rhodopsin (Visual Purple)IBA 02/2020
1	Insulin ReceptorIBA 01/2020
1	Pioglitazone (Actos)FDA Link 01/2020
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2020
1	B7-H1 AntigenIBA 12/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2019
1	Triglycerides (Triacylglycerol)IBA 03/2019
1	GhrelinIBA 03/2019
1	MethyltransferasesIBA 01/2019
1	phosphatidylethanolamineIBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Adenosine Triphosphatases (ATPase)IBA 01/2019
1	Membrane LipidsIBA 01/2019

Therapy/Procedure

6	Lasers (Laser) 01/2021 - 11/2010
5	Therapeutics 01/2021 - 06/2009
1	Orthopedic Procedures 01/2021
1	Sutures (Suture) 04/2020
1	Gastrectomy 03/2019